Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature
Crossref DOI link: https://doi.org/10.1186/s13023-017-0598-0
Published Online: 2017-03-16
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schoser, Benedikt
Fong, Edward
Geberhiwot, Tarekegn
Hughes, Derralynn
Kissel, John T.
Madathil, Shyam C.
Orlikowski, David
Polkey, Michael I.
Roberts, Mark
Tiddens, Harm A. W. M.
Young, Peter
Funding for this research was provided by:
BioMarin Pharmaceutical